NCT05429424

Brief Summary

A Taiwanese study pointed out that stroke patients who have language barriers, dysphagia, and aspiration pneumonia are more likely to suffer from prolonged hospitalization. Improvements in dysphagia and subsequent complications in patients should be effective in reducing hospital stays and improving the quality of long-term care. In view of clinical medical needs and policy trends, this study aims to explore the efficacy of using traditional Chinese medicine to treat cerebral apoplexy sequelae in Taiwan. It is expected that through (1) exploration of real-world data analysis, combined with the advantages of Taiwan's biomedical database, data exploration will be carried out to provide big data (2) Multi-center prospective randomized clinical trials, providing clinical evidence of the highest level of evidence in empirical medicine.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
336

participants targeted

Target at P75+ for not_applicable stroke

Timeline
Completed

Started Feb 2023

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 12, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 23, 2022

Completed
7 months until next milestone

Study Start

First participant enrolled

February 2, 2023

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2025

Completed
Last Updated

February 8, 2023

Status Verified

February 1, 2023

Enrollment Period

2.5 years

First QC Date

June 12, 2022

Last Update Submit

February 6, 2023

Conditions

Keywords

acupunctureswallowing impairment

Outcome Measures

Primary Outcomes (2)

  • dysphagia severity rating scale (DSRS)

    dysphagia severity rating scale(DSRS) indicates the feeding status of the dysphagia patient in three subdomains: fluids, diet, and level of supervision required for feeding. The total score from 0 to 12. The higher scores means the better outcome. Changes from baseline to the 2nd week of the intervention, the 1st and 4th week of follow-up period.

    baseline, the 2nd week of the intervention, 1st and 4th week of follow-up period

  • the functional oral intake scale (FOIS)

    the functional oral intake scale(FOIS) is used to assessing the functional level of oral intake of food and liquid in stroke patients. It is a 7-point scale, with level 1 indicating complete impairment of oral intake, and level 7 indicating complete oral intake regardless of food consistency or type. Changes from baseline to the 2nd week of the intervention, the 1st and 4th week of follow-up period.

    baseline, the 2nd week of the intervention, 1st and 4th week of follow-up period

Study Arms (3)

Verum acupuncture group

EXPERIMENTAL

The study uses manual acupuncture as verum intervention.

Other: Verum acupuncture group

Sham control group I

SHAM COMPARATOR

The study used specific made needle with a blunt tip, Streitberger device, as sham intervention.

Other: Sham control group I

Sham control group II

SHAM COMPARATOR

Manual acupuncture at the points unrelated to the dysphagia is another sham intervention in this study.

Other: Sham control group II

Interventions

The acupuncturist disinfected the skin of the selected acupoints with alcohol, then vertically penetrated the skin with disposable stainless-steel needles (size, brand, Taiwan) to the depth predetermined for each point (between 8-25 mm, depending on the location of the acupoint) and achieved a "deqi" response, often described as a pressure, fullness, or achiness feeling around the acupoints.

Verum acupuncture group

The needle does not penetrate the skin and retract in the handle while the acupuncturist needling into the skin. The participants easily believe their intervention owing to the sensation of needling into the skin that the device mimics. The needles were fixed with a plastic ring and micropore on the body of the participants without manipulation.

Sham control group I

The acupuncturist disinfected the skin of the selected acupoints with alcohol, then vertically penetrated the skin with disposable stainless-steel needles (size, brand, Taiwan) to the depth predetermined for each point (between 8-25 mm, depending on the location of the acupoint) and achieved a "deqi" response, often described as a pressure, fullness, or achiness feeling around the acupoints.

Sham control group II

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged more than 20 years
  • The diagnosis of first stroke was established within the six months
  • Patients had a score ≥ 25 of Mini-Mental State Examination (MMSE)
  • Patients met one or both indications as follows
  • Dysphagia confirmed under the standardized swallowing assessment
  • Nasogastric tube feeding already

You may not qualify if:

  • Previous history of swallowing disability
  • Currently known coagulopathy leading to bleeding disorder.
  • Previous surgery of head or neck
  • Local infection at or near the acupuncture site is not suitable for acupuncture after physician examination.
  • Psychological or behavior disorder
  • Currently pregnant or breastfeeding women.
  • Previous acupuncture treatment for any indication within 30 days of enrollment.
  • Severe chronic or uncontrollable complications interference the processing of the trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

China Medical University Hospital

Taichung, Taiwan

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • China Medicine University China Medicine University

    China Medicine University

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
In this study, the participants, assessor, and statistician are all blinded to the treatment assignments except for the acupuncturist and study coordinator.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 12, 2022

First Posted

June 23, 2022

Study Start

February 2, 2023

Primary Completion

July 31, 2025

Study Completion

July 31, 2025

Last Updated

February 8, 2023

Record last verified: 2023-02

Locations